Hanneke Doremiek van Oorschot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hanneke Doremiek van Oorschot has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Jose Angelito Hardillo
Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands
8 shared publications - Robert Jan Baatenburg de Jong
Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands
8 shared publications - Dominique Valerie Clarence de Jel
Department of Otorhinolaryngology/Head and Neck Surgery, University Medical Centre Groningen University of Groningen Groningen The Netherlands
5 shared publications - Alexander J. M. van Bemmel
Department of Otorhinolaryngology and Head and Neck Surgery Medisch Spectrum Twente Enschede The Netherlands
4 shared publications - Gyorgy Bela Halmos
University Medical Center Groningen 4 Department of Otorhinolaryngology – Head and Neck Surgery Groningen, the Netherlands
4 shared publications - Lauretta Anna Alexandra Vaassen
Deputy Head, Head and Neck Oncologist, Department of Cranio-Maxillofacial Surgery, Maastricht Comprehensive Cancer Center, Maastricht University Medical Center, Maastricht, The Netherlands
4 shared publications
Latest Publications
- 13 February 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (7) , 2085-2086
Authors' Reply “Preoperative Staging in Oral Cavity Cancer: Nationwide Practice and Concordance With Pathology”
- 13 February 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (7) , 2085-2086
Authors' Reply “Preoperative Staging in Oral Cavity Cancer: Nationwide Practice and Concordance With Pathology”
- 5 December 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (3)
In Response to Surgical Complications for Oral Cavity Cancer: Evaluating Hospital Performance
- 5 December 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (3)
In Response to Surgical Complications for Oral Cavity Cancer: Evaluating Hospital Performance
- Open Access
- 31 August 2025
- Published by Wiley in Oral Diseases
- Vol. 32 (2) , 395-404
Preoperative Staging in Oral Cavity Cancer: Nationwide Practice and Concordance With Pathology
Objectives: The clarity of TNM‐classification for oral cancer has a direct impact on healthcare resource allocation, treatment decisions, morbidity, and clinical outcomes. However, possible TNM ambiguity between hospitals exists due to the broad range of available diagnostics. Therefore, this study aims to assess current practice variation in preoperative staging for oral cavity cancer. Materials and Methods: All patients who underwent primary oral cavity cancer resection in the Netherlands between 2018 and 2021 were selected from the Dutch Head and Neck Audit database. Preoperative staging (cTN) was compared to definitive pathology staging (pTN) as the gold standard for assessing concordance at national and hospital levels. Results: Disease stage was upstaged in 27.5% of the patients. For T‐classification analysis, 2458 patients were included. Accuracy for T‐classification categories was 85.2%–93.1%, but significant hospital variation in overstaging and understaging was observed. For N‐classification analysis, 1746 patients were included. Preoperative assessment of node involvement missed metastasis in 25.1% of the cN0 patients, resulting in 77.3% accuracy. Conclusion: Significant preoperative understaging of oral cancer calls the attention to the difficulties of the diagnostics of oral cancer. Although the accuracy of preoperative staging in oral cavity cancer is high, significant differences between hospitals were observed.
- 31 August 2025
- Published by Wiley in Oral Diseases
- Vol. 32 (2) , 395-404
Open AccessPreoperative Staging in Oral Cavity Cancer: Nationwide Practice and Concordance With Pathology
Objectives: The clarity of TNM‐classification for oral cancer has a direct impact on healthcare resource allocation, treatment decisions, morbidity, and clinical outcomes. However, possible TNM ambiguity between hospitals exists due to the broad range of available diagnostics. Therefore, this study aims to assess current practice variation in preoperative staging for oral cavity cancer. Materials and Methods: All patients who underwent primary oral cavity cancer resection in the Netherlands between 2018 and 2021 were selected from the Dutch Head and Neck Audit database. Preoperative staging (cTN) was compared to definitive pathology staging (pTN) as the gold standard for assessing concordance at national and hospital levels. Results: Disease stage was upstaged in 27.5% of the patients. For T‐classification analysis, 2458 patients were included. Accuracy for T‐classification categories was 85.2%–93.1%, but significant hospital variation in overstaging and understaging was observed. For N‐classification analysis, 1746 patients were included. Preoperative assessment of node involvement missed metastasis in 25.1% of the cN0 patients, resulting in 77.3% accuracy. Conclusion: Significant preoperative understaging of oral cancer calls the attention to the difficulties of the diagnostics of oral cancer. Although the accuracy of preoperative staging in oral cavity cancer is high, significant differences between hospitals were observed.
- Open Access
- 26 June 2025
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 63 (9) , 664-671
Hospital-level variation in resection margins after oral cavity cancer surgery and associated survival outcomes
- 26 June 2025
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 63 (9) , 664-671
Open AccessHospital-level variation in resection margins after oral cavity cancer surgery and associated survival outcomes
- Open Access
- 24 June 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (5) , 1158-1169
Textbook Outcome After Oral Cancer Surgery as a Composite Measure for Survival and Quality‐of‐Care Evaluation
Objective: To enhance survival outcomes for oral cavity cancer (OCC) surgery, a composite measure has been developed: “textbook outcome” (TO). Three studies have reported on this concept in OCC, but the need for population‐level results remains. This study investigates OCC surgery, focusing on survival and hospital‐level results. Study Design: Cohort study. Setting: National multicenter study. Methods: All first primary OCC patients who underwent curative tumor resection between 2018 and 2021 were selected from the Dutch Head and Neck Audit database. Resections were categorized as local or extensive, the latter including neck dissection and/or free or pedicled flap reconstruction. TO was defined as the absence of 30‐day mortality, hospital readmission, prolonged length‐of‐stay, severe complications, surgical margins P = .004, 0.70 DFS P = .085) and extensive (aHR 0.61 OS P ≤ .001, 0.69 DFS P = .002) surgery. After correction for population differences, no interhospital variation in TO remained. Conclusion: Achieving TO is strongly linked to improved survival, highlighting its importance as a short‐term composite quality‐of‐care indicator. The separate outcomes that were influential to the hospital's TO score differed between hospitals, indicating opportunities to improve outcomes.
- 24 June 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (5) , 1158-1169
Open AccessTextbook Outcome After Oral Cancer Surgery as a Composite Measure for Survival and Quality‐of‐Care Evaluation
Objective: To enhance survival outcomes for oral cavity cancer (OCC) surgery, a composite measure has been developed: “textbook outcome” (TO). Three studies have reported on this concept in OCC, but the need for population‐level results remains. This study investigates OCC surgery, focusing on survival and hospital‐level results. Study Design: Cohort study. Setting: National multicenter study. Methods: All first primary OCC patients who underwent curative tumor resection between 2018 and 2021 were selected from the Dutch Head and Neck Audit database. Resections were categorized as local or extensive, the latter including neck dissection and/or free or pedicled flap reconstruction. TO was defined as the absence of 30‐day mortality, hospital readmission, prolonged length‐of‐stay, severe complications, surgical margins P = .004, 0.70 DFS P = .085) and extensive (aHR 0.61 OS P ≤ .001, 0.69 DFS P = .002) surgery. After correction for population differences, no interhospital variation in TO remained. Conclusion: Achieving TO is strongly linked to improved survival, highlighting its importance as a short‐term composite quality‐of‐care indicator. The separate outcomes that were influential to the hospital's TO score differed between hospitals, indicating opportunities to improve outcomes.
- Open Access
Cohort profile: the Dutch oral cavity cancer cohort
Purpose The Dutch Head and Neck Audit–Oral Cavity (DHNA-OC) cohort was collected to study the quality of care, current treatment and survival for oral cavity cancer (OCC) across all hospitals treating head and neck cancer (HNC) in the Netherlands. Patients The DHNA-OC is a registry-based national cohort of 2545 first primary OCC patients treated with curative intent between 2018 and 2021. All 14 HNC hospitals in the Netherlands contributed, guaranteeing national coverage. The DHNA-OC cohort is an elaborate dataset including variables on patient and tumour characteristics, treatment, complications, recurrence rates and survival. Findings to date The median age at diagnosis was 67 years and most tumours were early stage (cT1 in 32% and cT2 in 31%). Tongue tumours were most common, and surgery was performed in 91.3% of the patients. The number of included patients per hospital varied from 82 to 367. The proportion of advanced tumour stage varied significantly between hospitals. Substantial data completeness was acquired with only two variables exceeding 10% missing (comorbidities and performance score). Future plans The DHNA-OC cohort will be used to study benchmarking of and current knowledge gaps in OCC care. Collaboration with other institutions or national/regional databases is highly encouraged. Some examples of planned studies are the assessment of hospital variation in outcome indicators for surgery and population-based treatment effects. The results of these studies will be used to identify best practices and continue improving the quality of care. Longitudinal cohort follow-up and enrolment will continue prospectively.
Open AccessCohort profile: the Dutch oral cavity cancer cohort
Purpose The Dutch Head and Neck Audit–Oral Cavity (DHNA-OC) cohort was collected to study the quality of care, current treatment and survival for oral cavity cancer (OCC) across all hospitals treating head and neck cancer (HNC) in the Netherlands. Patients The DHNA-OC is a registry-based national cohort of 2545 first primary OCC patients treated with curative intent between 2018 and 2021. All 14 HNC hospitals in the Netherlands contributed, guaranteeing national coverage. The DHNA-OC cohort is an elaborate dataset including variables on patient and tumour characteristics, treatment, complications, recurrence rates and survival. Findings to date The median age at diagnosis was 67 years and most tumours were early stage (cT1 in 32% and cT2 in 31%). Tongue tumours were most common, and surgery was performed in 91.3% of the patients. The number of included patients per hospital varied from 82 to 367. The proportion of advanced tumour stage varied significantly between hospitals. Substantial data completeness was acquired with only two variables exceeding 10% missing (comorbidities and performance score). Future plans The DHNA-OC cohort will be used to study benchmarking of and current knowledge gaps in OCC care. Collaboration with other institutions or national/regional databases is highly encouraged. Some examples of planned studies are the assessment of hospital variation in outcome indicators for surgery and population-based treatment effects. The results of these studies will be used to identify best practices and continue improving the quality of care. Longitudinal cohort follow-up and enrolment will continue prospectively.
- Open Access
- 6 February 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (7) , 2411-2419
Surgical Complications for Oral Cavity Cancer: Evaluating Hospital Performance
Objective: Complications of oral cavity cancer (OCC) surgery have an impact on the quality of life. Therefore, evaluating hospital performance on complication rates can help identify best practices for improving the quality of OCC care. As patient and tumor characteristics also impact hospital results, case‐mix adjustment should be considered to provide a valid hospital comparison. This study investigated hospital variation in the quality indicator “a complicated postoperative course” after OCC surgery. Methods: This population‐based cohort included all first primary OCC patients diagnosed between 2018 and 2021 who were surgically treated with curative intent. A complicated postoperative course was defined as 30‐day mortality, unplanned readmission, surgical complications requiring reintervention or prolonged hospital stay, or fistula formation. Hospital performance was analyzed using funnel plots with case‐mix correction. Results: A total of 2,266 OCC patients could be included. The distribution of case‐mix variables varied significantly between hospital populations. Nationally, a complicated postoperative course occurred in 13.9% and uncorrected hospital rates ranged from 2.7% to 31.1%. A WHO performance score ≥2, cT3‐T4 tumors, and floor‐of‐mouth tumors were associated with an increased risk of a complicated postoperative course, and non‐squamous cell carcinoma with a decreased risk. Significant outliers remained after case‐mix correction for patient, tumor, and treatment characteristics. Conclusion: Complications after OCC surgery are prevalent, especially regarding extensive tumors and surgery. To identify best practices in OCC surgery, hospital performance on a complicated postoperative course should be adjusted for case‐mix and treatment variables. Providing feedback on hospital performance for complications can instigate improvement plans for better outcomes. Level of Evidence: 3 Laryngoscope , 135:2411–2419, 2025
- 6 February 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (7) , 2411-2419
Open AccessSurgical Complications for Oral Cavity Cancer: Evaluating Hospital Performance
Objective: Complications of oral cavity cancer (OCC) surgery have an impact on the quality of life. Therefore, evaluating hospital performance on complication rates can help identify best practices for improving the quality of OCC care. As patient and tumor characteristics also impact hospital results, case‐mix adjustment should be considered to provide a valid hospital comparison. This study investigated hospital variation in the quality indicator “a complicated postoperative course” after OCC surgery. Methods: This population‐based cohort included all first primary OCC patients diagnosed between 2018 and 2021 who were surgically treated with curative intent. A complicated postoperative course was defined as 30‐day mortality, unplanned readmission, surgical complications requiring reintervention or prolonged hospital stay, or fistula formation. Hospital performance was analyzed using funnel plots with case‐mix correction. Results: A total of 2,266 OCC patients could be included. The distribution of case‐mix variables varied significantly between hospital populations. Nationally, a complicated postoperative course occurred in 13.9% and uncorrected hospital rates ranged from 2.7% to 31.1%. A WHO performance score ≥2, cT3‐T4 tumors, and floor‐of‐mouth tumors were associated with an increased risk of a complicated postoperative course, and non‐squamous cell carcinoma with a decreased risk. Significant outliers remained after case‐mix correction for patient, tumor, and treatment characteristics. Conclusion: Complications after OCC surgery are prevalent, especially regarding extensive tumors and surgery. To identify best practices in OCC surgery, hospital performance on a complicated postoperative course should be adjusted for case‐mix and treatment variables. Providing feedback on hospital performance for complications can instigate improvement plans for better outcomes. Level of Evidence: 3 Laryngoscope , 135:2411–2419, 2025
- 7 November 2024
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 63 (3) , 195-202
Nationwide clinical practice variation for reconstructive surgery following oral cavity cancer from the Dutch Head and Neck Audit: are we all doing the same?
- 7 November 2024
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 63 (3) , 195-202
Nationwide clinical practice variation for reconstructive surgery following oral cavity cancer from the Dutch Head and Neck Audit: are we all doing the same?
- Open Access
- 1 January 2024
- Published by SAGE Publications in Trends in Hearing
- Vol. 28
Sound Localization in Single-Sided Deafness; Outcomes of a Randomized Controlled Trial on the Comparison Between Cochlear Implantation, Bone Conduction Devices, and Contralateral Routing of Signals Hearing Aids
There is currently a lack of prospective studies comparing multiple treatment options for single-sided deafness (SSD) in terms of long-term sound localization outcomes. This randomized controlled trial (RCT) aims to compare the objective and subjective sound localization abilities of SSD patients treated with a cochlear implant (CI), a bone conduction device (BCD), a contralateral routing of signals (CROS) hearing aid, or no treatment after two years of follow-up. About 120 eligible patients were randomized to cochlear implantation or to a trial period with first a BCD on a headband, then a CROS (or vice versa). After the trial periods, participants opted for a surgically implanted BCD, a CROS, or no treatment. Sound localization accuracy (in three configurations, calculated as percentage correct and root-mean squared error in degrees) and subjective spatial hearing (subscale of the Speech, Spatial and Qualities of hearing (SSQ) questionnaire) were assessed at baseline and after 24 months of follow-up. At the start of follow-up, 28 participants were implanted with a CI, 25 with a BCD, 34 chose a CROS, and 26 opted for no treatment. Participants in the CI group showed better sound localization accuracy and subjective spatial hearing compared to participants in the BCD, CROS, and no-treatment groups at 24 months. Participants in the CI and CROS groups showed improved subjective spatial hearing at 24 months compared to baseline. To conclude, CI outperformed the BCD, CROS, and no-treatment groups in terms of sound localization accuracy and subjective spatial hearing in SSD patients. TRIAL REGISTRATION Netherlands Trial Register ( https://onderzoekmetmensen.nl ): NL4457, CINGLE trial.
- 1 January 2024
- Published by SAGE Publications in Trends in Hearing
- Vol. 28
Open AccessSound Localization in Single-Sided Deafness; Outcomes of a Randomized Controlled Trial on the Comparison Between Cochlear Implantation, Bone Conduction Devices, and Contralateral Routing of Signals Hearing Aids
There is currently a lack of prospective studies comparing multiple treatment options for single-sided deafness (SSD) in terms of long-term sound localization outcomes. This randomized controlled trial (RCT) aims to compare the objective and subjective sound localization abilities of SSD patients treated with a cochlear implant (CI), a bone conduction device (BCD), a contralateral routing of signals (CROS) hearing aid, or no treatment after two years of follow-up. About 120 eligible patients were randomized to cochlear implantation or to a trial period with first a BCD on a headband, then a CROS (or vice versa). After the trial periods, participants opted for a surgically implanted BCD, a CROS, or no treatment. Sound localization accuracy (in three configurations, calculated as percentage correct and root-mean squared error in degrees) and subjective spatial hearing (subscale of the Speech, Spatial and Qualities of hearing (SSQ) questionnaire) were assessed at baseline and after 24 months of follow-up. At the start of follow-up, 28 participants were implanted with a CI, 25 with a BCD, 34 chose a CROS, and 26 opted for no treatment. Participants in the CI group showed better sound localization accuracy and subjective spatial hearing compared to participants in the BCD, CROS, and no-treatment groups at 24 months. Participants in the CI and CROS groups showed improved subjective spatial hearing at 24 months compared to baseline. To conclude, CI outperformed the BCD, CROS, and no-treatment groups in terms of sound localization accuracy and subjective spatial hearing in SSD patients. TRIAL REGISTRATION Netherlands Trial Register ( https://onderzoekmetmensen.nl ): NL4457, CINGLE trial.